Affiliation:
1. Department of Thoracic Surgery, Ganzhou Key Laboratory of Respiratory Diseases, Ganzhou Institute of Respiratory Diseases, The Fifth People’s Hospital of Ganzhou, Ganzhou, Jiangxi, 341000, China
Abstract
Non-small cell lung cancer (NSCLC) is one of the most common lung cancers, accounting for more than 85% of lung cancer incidence rates and seriously endangering human health. Increasing evidence shows that some long non-coding RNAs (lncRNAs) act as tumor suppressors and some promote
cancer. Pterostilbene-regulated lncRNA-linc00511 has been confirmed to be an oncogenic gene in a variety of tumors. This study aimed to determine the biological function of pterostilbene-regulated lncRNA-linc00511 (LINC00511) in non-small cell lung cancer and provide new diagnostic and therapeutic
targets for it. Lung cancer A549 cells were randomly divided into control group and hypoxic group. siRNA knockdown and LINC00511 overexpression plasmid were constructed under hypoxic conditions. Pterostilbene was used to intervene with lncRNA-linc00511. Real time PCR was used to detect the
expression changes of LINC00511 and MiR-184. Analyze and detect the effect on the proliferation and invasion of non-small cell lung cancer cells under hypoxic conditions. Real time PCR analysis was used to detect the expression changes of EMT molecules E-cadherin and Vimentin. Western blot
detected changes in HIF-1α expression. The expression of LINC00511 increased and the expression of MiR-184 decreased in lung cancer A549 cells, and hypoxic environment led to more significant changes in both. After siRNA knocked down the expression of LINC00511 under hypoxic conditions,
pterostilbene was used to intervene with lncRNA-linc00511. The results showed that it promoted the expression of MiR-184, inhibited the proliferation and invasion of lung cancer cells, upregulated the expression of EMT molecules E-cadherin, and increased the expression of Vimentin. The expression
is reduced and the expression of HIF-1α is downregulated. Overexpression of LINC00511 can reverse the above changes. Under hypoxic conditions, pterostilbene was used to interfere with lncRNA-linc00511 to promote cell proliferation in non-small cell lung cancer cells. Pterostilbene’s
intervention with lncRNA-linc00511 could target the expression of MiR-184 to promote the proliferation and invasion of non-small cell lung cancer. Knocking down the expression of LINC00511 can target down-regulate the expression of MiR-184, change the occurrence of EMT, and alleviate the occurrence
and progression of non-small cell lung cancer.
Publisher
American Scientific Publishers
Reference30 articles.
1. Non-small cell lung cancer: Epidemiology, risk factors, treatment, and survivorship;Molina;Mayo Clinic Proceedings,2008
2. Causes of death and competing risk analysis of the associated factors for non-small cell lung cancer using the surveillance, epidemiology, and end results database;Wei;Journal of Cancer Research and Clinical Oncology,2018
3. Cancer progress and priorities: Lung cancer;Schabath;Cancer Epidemiology, Biomarkers & Prevention,2019
4. Symptoms and the early diagnosis of lung cancer;Birring;Thorax,2005
5. Eliciting symptoms interpreted as normal by patients with early-stage lung cancer: Could GP elicitation of normalised symptoms reduce delay in diagnosis? cross-sectional interview study;Brindle;BMJ Open,2012